TISSUE MICROARRAY COLLECTIONS

Melanoma tissue microarrays & FFPE blocks

Explore melanoma arrays by tissue composition and treatment setting, including selected immunotherapy-follow-up collections. For FFPE blocks, share your tissue and study requirements with our team.

THE ARRAYS

Melanoma arrays (7)

Collection types in this TMA catalog

Explore the tissue composition and sampling groups represented in these arrays.

Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.

FFPE TISSUE BLOCKS

Melanoma FFPE blocks for your study

Melanoma FFPE profiles include resectable stage III/IV disease and before or after immunotherapy or checkpoint inhibitor treatment.

FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.

COHORT HIGHLIGHTS

Representative FFPE cohort profiles

These examples are a starting point. Explore the corresponding FFPE indication for the full set of documented profiles and associated data.

Selected examples, not live inventory. Tissue and data availability are confirmed for your study.

SELECTING YOUR ARRAY

Selecting melanoma tissue for your study

Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.

Melanoma TMA: Immunotherapy Follow-up

This melanoma tissue microarray includes pre-treatment and post-immunotherapy samples with pembrolizumab/nivolumab follow-up data. The pre- and post-treatment groups are not donor matched.

Metastatic Melanoma TMA: Treatment Follow-up

This stage III–IV melanoma tissue microarray lists primary and metastatic tissue with follow-up covering first-line chemotherapy and second-line immunotherapy. Review individual records for the treatment histories available.

Melanoma TMA: Pre/Post Treatment

This malignant melanoma tissue microarray includes pre- and post-treatment samples with follow-up data. The pre/post samples are not donor matched.